z-logo
open-access-imgOpen Access
Could we reverse memory loss in Alzheimer’s patients? Mice answer yes!
Author(s) -
Aude Marzo,
Faye McLeod,
Patricia C. Salinas
Publication year - 2017
Publication title -
thesciencebreaker
Language(s) - English
Resource type - Journals
ISSN - 2571-9262
DOI - 10.25250/thescbr.brk042
Subject(s) - psychology , cognitive science , computer science , psychoanalysis , neuroscience
Aβ can affect the levels of certain molecules in the brain, one in parAcular is called Dickkopf-1 (Dkk1). This is interesAng because Dkk1 is an inhibitor of a family of proteins named Wnts, which have recently been suspected to be dys regu la ted in A l zhe imer ’ s d i sease . Importantly, an upregulaAon of Dkk1 is found in the brains of Alzheimer’s paAents. Also, Aβ elevates Dkk1 levels and blockade of Dkk1 protects synapses f rom Aβ-med ia ted degeneraAon. Our group decided to further invesAgate the effects of Dkk1 by varying its level in the brain. To achieve this, we used a laboratory technique widely used to engineer geneAcally modified mice that can produce different levels of a specific molecule at the scienAst’s will. To understand the effect of Dkk1 in the brain, we used a mouse which has more Dkk1 (let’s call it a “Dkk1-mouse”) than healthy mice. Hence, the Dkk1-mouse could mimic the changes brought on by Aβ.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom